Oestrogen and weight loss decrease isoproterenol-induced Fos immunoreactivity and angiotensin type 1 mRNA in the

Eric G Krause1, Kathleen S Curtis, Todd L Stincic

  • 1Department of Psychology, Program in Neuroscience, Florida State University, Tallahassee, FL 32303-1270, USA.

Insights

Weight loss, not estrogen, reduces isoproterenol-induced water intake in female rats by decreasing angiotensin II type 1 receptor expression in the brain.

Area of Science:

  • Neuroendocrinology
  • Behavioral Neuroscience
  • Cardiovascular Physiology

Background:

  • Estrogen influences angiotensin II (Ang II) effects on water intake and body weight.
  • Ovariectomy-induced weight gain can alter cardiovascular responses to Ang II.
  • The impact of weight changes on central Ang II responses is not well understood.

Purpose of the Study:

  • To investigate the roles of estrogen and weight loss in isoproterenol (Iso)-induced Fos immunoreactivity (IR) and angiotensin type 1 (AT1) receptor mRNA.
  • To examine the effects of weight loss on Iso-induced water intake and plasma renin activity (PRA).

Main Methods:

  • Rats were ovariectomized and treated with or without estrogen, or subjected to weight loss.
  • Fos IR and AT1 mRNA expression were measured in brain regions controlling fluid balance.
  • Water intake and PRA were assessed after Iso administration.

Main Results:

  • Isoproterenol increased Fos IR in key hypothalamic and forebrain nuclei.
  • Both estrogen and weight loss attenuated Iso-induced Fos IR and AT1 mRNA in the subfornical organ (SFO).
  • Weight loss, but not estrogen, reduced Iso-induced water intake without affecting PRA.

Conclusions:

  • Weight loss, independent of estrogen, decreases Ang II-elicited water intake.
  • This effect is likely mediated by reduced AT1 receptor expression in the SFO.
  • Findings highlight the role of weight changes in modulating central Ang II signaling.